LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,889 | +20.9% | 5,209 | +24.2% | 0.00% | 0.0% |
| Q2 2023 | $289,443 | +33.6% | 4,193 | -6.7% | 0.00% | 0.0% |
| Q1 2023 | $216,604 | -19.0% | 4,492 | -16.2% | 0.00% | 0.0% |
| Q4 2022 | $267,471 | +17.3% | 5,358 | +29.1% | 0.00% | 0.0% |
| Q2 2022 | $228,000 | +12.9% | 4,149 | -25.4% | 0.00% | – |
| Q1 2022 | $202,000 | -30.8% | 5,565 | -11.2% | 0.00% | -100.0% |
| Q4 2021 | $292,000 | -15.4% | 6,267 | -8.2% | 0.00% | 0.0% |
| Q3 2021 | $345,000 | – | 6,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |